[
    [
        {
            "time": "",
            "original_text": "甘李药业：股东明华创新减持计划已实施完毕",
            "features": {
                "keywords": [
                    "甘李药业",
                    "明华创新",
                    "减持",
                    "实施完毕"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "甘李药业：股东明华创新减持计划已实施完毕",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "甘李药业：明华创新累计减持1%公司股份，减持完毕 减持股份",
            "features": {
                "keywords": [
                    "甘李药业",
                    "明华创新",
                    "累计减持",
                    "1%",
                    "股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "甘李药业：明华创新累计减持1%公司股份，减持完毕 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "甘李药业(603087.SH)：近日完成甘精胰岛素注射液糖尿病治疗研究的III期临床试验",
            "features": {
                "keywords": [
                    "甘李药业",
                    "甘精胰岛素",
                    "注射液",
                    "糖尿病",
                    "III期临床试验",
                    "完成"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业(603087.SH)：近日完成甘精胰岛素注射液糖尿病治疗研究的III期临床试验",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]